Cardiohemodynamics in patients with multiple myeloma depending on renal function


  • B. B. Samura Zaporizhzhia State Medical University, Ukraine,
  • M. O. Panasenko Zaporizhzhia State Medical University, Ukraine,



cardiohemodynamics, multiple myeloma, renal function


Purpose – to evaluate cardiohemodynamics in patients with multiple myeloma depending on renal function.

Materials and methods. Thirty-five subjects with multiple myeloma were enrolled in the study. They were divided into groups depending on the glomerular filtration rate (GFR). The first group involved 10 patients with GFR 30–59 ml/min/1.73 m2, the second one – 11 patients with GFR 60–89 ml/min/1.73 m2, the third one – 14 patients with normal renal function. All patients and control subjects underwent echocardiography.

Results. In patients with GFR 30–59 ml/min/1.73 m2 ejection fraction was significantly lower in comparing with healthy persons (54.69 [51.15; 57.70] % versus 59.82 [57.81; 62.29] %; P = 0.018) mainly due to decreased end systolic volume (ESV) (54.91 [43.21; 59.27] ml versus 34.22 [31.72; 41.24] ml; P = 0.035). In this group ESV was significantly lower in comparing with patients with normal renal function.

In patients with GFR 30–59 ml/min/1.73 m2 E (0.90 [0.76; 1.02] m/s versus 1,01 [1.02; 1.24]; P = 0.014), A (0.87 [0.76; 1.05] m/s versus 0.73 [0.56; 0.85] m/s; P = 0.023). E/A (9.30 [7.09; 11.15] versus 1.16 [1.06; 1.25]; P = 0.011) were significantly lower in in comparing with control. Global circular systolic strain (-17.62 [-21.09; -15.19] versus -25.92 [-26.09; -19.15]; P = 0.012) and global circular systolic strain rate (-1.26 [-1.30; -1.21] versus -1.32 [-1.42; -1.25]; P = 0.023) was significantly lower in group of patients with GFR 30–59 ml/min/1.73 m2 in comparing with healthy persons.

Conclusions. Our data suggest that the extent of renal function is directly associated with left ventricle diastolic and regional systolic parameters. Among patients with multiple myeloma and renal insufficiency systolic, diastolic and regional systolic contractility were significantly worse in comparing with patients with normal renal function and healthy persons.


Cowan, A., Allen, C., Barac, A., Basaleem, H., Bensenor, I., & Curado, M. et al. (2018). Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016. JAMA Oncology, 4(9), 1221-1227. doi: 10.1001/jamaoncol.2018.2128

Altekruse, S. F., Kosary, C. L., Krapcho, M., Neyman, N., Aminou, R., & Waldron, W. et al. (2010). SEER Cancer Statistics Review, 1975-2007. National Cancer Institute, Bethesda. Retrieved from

Turesson, I., Velez, R., Kristinsson, S., & Landgren, O. (2010). Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic. Mayo Clinic Proceedings, 85(3), 225-230. doi: 10.4065/mcp.2009.0426

Kuznietsova, L. P., & Panasenko, M. O. (2019). Komorbidna patolohiia u khvorykh na mnozhynnu miielomu [Comorbidities in patients with multiple myeloma]. Current issues in pharmacy and medicine: science and practice, 12 (2), 222-227. doi: 10.14739/2409-2932.2019.2.171245 [in Ukrainian].

Samura B. B. (2015). Prognosticheskaja rol galektina-3 u pacientov so mnozhestvennoj mielomoj v remissii [Predictive value of circulating galectin-3 in patients with multiple myeloma in remission]. Zaporozhye medical journal, 4(91), 11-16. doi: [in Russian].

Korbet, S., & Schwartz, M. (2006). Multiple Myeloma. Journal Of The American Society Of Nephrology, 17(9), 2533-2545. doi: 10.1681/asn.2006020139

Eleutherakis-Papaiakovou, V., Bamias, A., Gika, D., Simeonidis, A., Pouli, A., & Anagnostopoulos, A. et al. (2007). Renal failure in multiple myeloma: Incidence, correlations, and prognostic significance. Leukemia & Lymphoma, 48(2), 337-341. doi: 10.1080/10428190601126602

Dimopoulos, M., Kastritis, E., Rosinol, L., Bladé, J., & Ludwig, H. (2008). Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia, 22(8), 1485-1493. doi: 10.1038/leu.2008.131

Dimopoulos, M., Sonneveld, P., Leung, N., Merlini, G., Ludwig, H., & Kastritis, E. et al. (2016). International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment. Journal Of Clinical Oncology, 34(13), 1544-1557. doi: 10.1200/jco.2015.65.0044

(2015). Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi), tretynnoi (vysokospetsializovanoi) medychnoi dopomohy. Mnozhynna miieloma: nakaz MOZ Ukrainy vid 02.11.2015 roku №710. [Unified Clinical Protocols of primary, secondary (specialized) and tertiary (highly specialized) medical care. Multiple myeloma]. Retrieved from [in Ukrainian].

Gardin, J., Adams, D., Douglas, P., Feigenbaum, H., Forst, D., & Fraser, A. et al. (2002). Recommendations for a standardized report for adult transthoracic echocardiography: A report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. Journal Of The American Society Of Echocardiography, 15(3), 275-290. doi: 10.1067/mje.2002.121536

Otto K. M. (2019). Prakticheskaja jehokardiografija: Rukovodstvo po jehokardiograficheskoj diagnostike [Practical echocardiography: Guidelines for the Echocardiographic diagnostics]. Moscow: MEDpress-inform. [in Russian].

Lapach, S. N., Chubenko, A. V., & Babych, P. N. (2002). Statystyka v nauke y byznese [Statistics in science and business]. Kyiv: Morion. [in Russian].

How to Cite

Samura BB, Panasenko MO. Cardiohemodynamics in patients with multiple myeloma depending on renal function. CIPM [Internet]. 2019Nov.21 [cited 2023Dec.3];(3). Available from:



Original research